UNSPSC 41141820: Lipoprotein electrophoresis

In this classification, this entry connotes a substrate made of Lipoprotein electrophoresis that is used in clinical chemistry testing.

UNSPSC 41141820 Lipoprotein electrophoresis, a Commodity code, does not align with the recent state and local procurement activity tagged under it. The code nominally describes laboratory analysis services for lipoprotein separation and identification, but the recent solicitations show no such work. Instead, the opportunities posted under this code span consumable laboratory supplies, diagnostic reagents, and analytical instruments—including respiratory pathogen detection kits, culture media, solid-phase extraction disks, wastewater surveillance reagents, genomic sequencing kits, and mycobacterial identification products. The issuing bodies are state health departments (Texas HHSC, Mississippi State Department of Health, California), a university health science center, and a city government (Philadelphia), pursuing these supplies through IFBs, RFPs, and micro purchases. The mismatch between the code name and actual procurement suggests either a tagging error in the underlying procurement system or a coding convention issue within one or more state procurement offices.

The geographic spread of recent activity centers on Texas, Mississippi, and California, with one Philadelphia procurement. Texas Health and Human Services Commission is the most frequent issuer, with five separate IFBs posted between February and June 2026 for diagnostic consumables, extraction disks, culture media, chemical standards, and sequencing instruments, ranging from $25,000 to $393,000 in estimated value. Representative solicitations include HHSC IFB HHS0017272 (due May 19, 2026) for respiratory pathogen detection kits supporting wastewater surveillance at $35,000–$90,000 estimated value; HHSC IFB HHS0017132 (due June 2, 2026) for culture media for foodborne pathogen and listeria testing at $187,340 estimated value; Mississippi State Department of Health sole-source procurements for Clear Labs and Illumina sequencing reagents (objection deadline May 14, 2026) totaling $619,740; and University of Texas Health Science Center RFP 745-26-P19 (due June 4, 2026) for a comprehensive biotech research and clinical diagnostics catalog with baseline annual volume of approximately 8,768 line items. California issued two RFBs for mycobacterial reagents and Cerilliant certified spiking solutions in April 2026. Given the code–scope mismatch, firms pursuing this category should verify tagging accuracy with procurement offices and focus on suppliers of diagnostic reagents, sequencing consumables, and laboratory analytical supplies rather than lipoprotein electrophoresis services per se.